Is IHI a good investment?

iShares U.S. Medical Devices ETF (IHI) is a healthcare and biotech ETF. As of September 11, 2026, ETF Copilot scores IHI 4.9 out of 10 — highest on Valuation (9.8), lowest on Return (1.2). It trades at 30.0 times earnings, against its own median of 35.0. Its ten largest holdings are 75% of the fund.

Updated September 11, 2026

How is IHI rated? ETF Copilot scores iShares U.S. Medical Devices ETF (IHI) 4.9 out of 10

As of September 11, 2026, ETF Copilot scores iShares U.S. Medical Devices ETF (IHI) 4.9 out of 10 overall.

ETF Copilot scores (0–10 scale, higher is better):

Overall: 4.9 / 10
Growth: 6.9 / 10
Valuation: 9.8 / 10
Risk: 4.4 / 10
Quality: 2.9 / 10
Return: 1.2 / 10

IHI is ranked #7 of 10 in ETF Copilot's Thematic list.

What is IHI's expense ratio? 0.37% a year

As of September 11, 2026, IHI charges 0.37% a year, yields 1.00% and holds $3.4B in assets across 49 positions.

iShares U.S. Medical Devices ETF (IHI) — cost, income and size
Measure	IHI
Expense ratio	0.37%
Dividend yield	1.00%
Assets under management	$3.4B
Holdings	49

Expense ratio, dividend yield and assets under management are reported by the fund and refreshed daily. Every other figure on this page is computed by ETF Copilot.

What stands out in IHI's data

Tracks U.S. medical device companies, a niche within health care.

Its expected earnings growth runs ahead of the category median.

Growth estimate of 18% sits above the peer median of 16%.

Adds targeted exposure to medical device firms, a regulated corner of health care.

Why did IHI move this week? It fell 5.6% in the week to September 11, 2026 — Abbott Laboratories and Stryker drove it

IHI fell 5.6% in the week to September 11, 2026. The holdings that moved it most were Abbott Laboratories (−6.3%), Stryker (−10.5%) and Dexcom (−7.4%); Inspire Medical Systems (+17.5%) pushed the other way.

Is IHI expensive right now? It trades at 30.0 times earnings, against its own median of 35.0

As of September 11, 2026, IHI is cheaper than 88% of its own 114 monthly readings since 2017 — 14 of those months were cheaper than today.

Trailing twelve-month, computed by ETF Copilot from the fund's holdings rather than quoted from a data provider, and rebuilt nightly.

What's inside IHI?

What's inside IHI: Size (Large 74%, Mid 19%, Small 7%); Geography (International 9%, US 91%).

What are IHI's top holdings? The ten largest are 75% of the fund

Abbott Laboratories, Intuitive Surgical, Stryker, Becton Dickinson, Medtronic, Dexcom, ResMed, GE Healthcare Technolog-W/i, Edwards Lifesciences and Boston Scientific are IHI's largest holdings, in that order.

More concentrated than 94% of Healthcare & Biotech ETFs.

Half of IHI's weight sits in its 5 largest positions, and once those weights are taken into account it behaves like 12 equally weighted holdings.

Cite this

ETF Copilot, “iShares U.S. Medical Devices ETF (IHI) scores and holdings analysis”, as of September 11, 2026.
https://etf-copilot.com/etf/ihi